Reperfusion of the infarct-related coronary artery limits left ventricular expansion beyond myocardial salvage.
Previous echocardiographic data from the Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI 1) trial suggest that the relation between left ventricular end-systolic volume and infarct size could be altered by thrombolysis, which would exert a restraining effect on end-systolic volume beyond its reducing effect on infarct size. Thus in 63 patients with one-vessel disease and a recent anterior myocardial infarction, we tested at angiography (1) if perfusion of the anterior descending coronary artery exerts any restraining effect on end-systolic volume above and beyond infarct size reduction and (2) if ejection fraction reflects such an additional, beneficial difference in the ventricular remodeling process. End-systolic volume was calculated using the Dodge method and the right anterior oblique projection, while infarct size was quantified according to the number of ventricular radii whose percent shortening fell below the mean -2 SD of a group of normal individuals. Patients were then divided into two groups according to the perfusion status of the vessel using Thrombolysis in Myocardial infarction (TIMI) criteria (TIMI grade 0 to 1: nonperfused vessel, 27 patients; TIMI grade 2 to 3: perfused vessel, 36 patients). For both groups there was a significant linear relation (p less than 0.001) between end-systolic volume and infarct size; as in our echocardiographic data, the regression lines relating volume to infarct size showed a different slope in the two populations so that, for large and matched infarcts, end-systolic volume was smaller in patients with a perfused vessel (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Marino
P
P
Division of Cardiology, University of Verona, Italy.
Destro
G
G
Barbieri
E
E
Bicego
D
D
D000368:Aged; D001794:Blood Pressure; D002302:Cardiac Output / Q000187:drug effects*; D002306:Cardiac Volume / Q000187:drug effects*; D003198:Computer Simulation; D017023:Coronary Angiography; D005260:Female; D015637:Gated Blood-Pool Imaging; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008955:Models, Cardiovascular; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D015425:Myocardial Reperfusion; D012189:Retrospective Studies; D013300:Streptokinase / Q000494:pharmacology* / Q000627:therapeutic use; D013318:Stroke Volume / Q000187:drug effects; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000494:pharmacology* / Q000627:therapeutic use; D016276:Ventricular Function / Q000187:drug effects*
D013300:Streptokinase; D010959:Tissue Plasminogen Activator